Stocks · Healthcare · Biotechnology
Verastem, Inc. VSTM
$8.00 +3.90% Close, Oct 5, 2026 · NASDAQ · Market cap $676.6M
Strong growth
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $87.5M, up 3995.7% from a year earlier, accelerating from 395.8% a quarter earlier.
- Operating margin widened to -182.6% from -7326.1% a year earlier.
- The diluted share count rose 35.2% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 1%
- Revenue growth, 3-year CAGRTop 6%
- Revenue growth accelerationTop 1%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 8%
- Gross marginTop 23%
- Operating marginBottom 25%
- Accruals (lower is better)Top 14%
- Interest coverBottom 12%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 23%
- Free-cash-flow yieldBottom 22%
- EBITDA / enterprise valueBottom 21%
- Sales / enterprise valueBottom 38%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 30%
- 6-month returnTop 23%
- 1-year return vs S&P 500Bottom 35%
- Distance from 52-week highTop 40%
- Trend checklist (0–4)Top 10%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 18%
- Consecutive EPS beatsTop 25%
- Share of analysts rating BuyTop 48%
- Upside to consensus price targetTop 43%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 46%
- Maximum drawdown, 3 yearsBottom 26%
- Beta vs S&P 500 (lower is better)Top 41%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 395.8% | 3995.7% | ↑ |
| Gross margin | 79.1% | 86.7% | ↑ |
| Operating margin | -7326.1% | -182.6% | ↑ |
| FCF margin | -5626.3% | -186.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 3995.7% | 395.8% | ↑ | Top 1% |
| Gross margin | 86.7% | 79.1% | ↑ | Top 23% |
| Operating margin | -182.6% | -7326.1% | ↑ | Bottom 25% |
| Net margin | -231.6% | -7793.9% | ↑ | — |
| Free-cash-flow margin | -186.8% | -5626.3% | ↑ | — |
| Return on invested capital | -118.5% | — | Bottom 8% | |
| Revenue growth, 3-year CAGR | 128.4% | — | Top 6% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -19.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 11.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -2818.3 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -108.3×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -21.63%
- Shareholder yield
- -21.63%
- Share count change, 1 year
- +35.2%
- Share count change, 3-year CAGR
- +78.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- -26.5%
- Average 2-day reaction, last 8
- -2.6%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $14.43
- Target vs current price
- +80.4%
- Analysts with a rating
- 19
- Share rating Buy or Strong Buy
- 79%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +18.7% | +0.7% | +18.4% | +36.6% | — |
| May 7, 2026 | +19.6% | -5.8% | -21.5% | -35.8% | -5.3% |
| Mar 4, 2026 | +20.4% | +2.3% | +12.5% | -6.7% | -24.5% |
| Nov 4, 2025 | -164.7% | -20.1% | -16.7% | -1.2% | -38.4% |
| Aug 7, 2025 | +54.1% | -1.7% | +40.2% | +84.6% | +61.4% |
| May 13, 2025 | -33.3% | +2.3% | +6.3% | -16.0% | -22.9% |
| Mar 20, 2025 | -64.2% | -2.3% | -8.3% | -28.9% | -19.8% |
| Nov 6, 2024 | +15.5% | +3.5% | +17.6% | +46.8% | +57.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.35 | -$0.43 | +18.7% | $40.1M |
| May 7, 2026 | -$0.37 | -$0.46 | +19.6% | $18.7M |
| Mar 4, 2026 | -$0.39 | -$0.49 | +20.4% | $17.5M |
| Nov 4, 2025 | -$1.35 | -$0.51 | -164.7% | $11.2M |
| Aug 7, 2025 | -$0.39 | -$0.85 | +54.1% | $2.1M |
| May 13, 2025 | -$0.96 | -$0.72 | -33.3% | — |
| Mar 20, 2025 | -$1.33 | -$0.81 | -64.2% | $10.0M |
| Nov 6, 2024 | -$0.60 | -$0.71 | +15.5% | — |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 7.14× | — | — | Bottom 38% |
| Free-cash-flow yield | -24.17% | — | — | Bottom 22% |
| Earnings yield | -30.75% | — | — | Bottom 23% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 64
- Days above the 200-day average
- 41
- 50-day average slope (20 days)
- +16.8%
- 200-day average slope (20 days)
- -3.4%
- Distance from 50-day average
- +11.0%
- Distance from 200-day average
- +32.6%
- RSI (14)
- 57.0
- Relative volume
- 0.93×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 58.2%
- Volatility vs own 5-year history
- 9th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.97
- Correlation with S&P 500
- 0.14
- Current drawdown from 1-year high
- -24.8%
- Maximum drawdown, 3 years
- -84.4%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 21, 2021 | Aug 5, 2024 | -96.2% | 785 days | Not yet recovered |
| Jan 8, 2021 | Jan 28, 2021 | -24.9% | 13 days | 13 days (Feb 17, 2021) |
| Feb 17, 2021 | Mar 4, 2021 | -21.3% | 11 days | 22 days (Apr 6, 2021) |
| Oct 9, 2020 | Oct 28, 2020 | -17.9% | 13 days | 9 days (Nov 10, 2020) |
| Dec 10, 2020 | Dec 31, 2020 | -11.3% | 14 days | 5 days (Jan 8, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $676.6M
- EPS, diluted (TTM)
- -$2.46
- Revenue (TTM)
- $87.5M
- 52-week range
- $3.43 – $10.82
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.1M | $2.6M | $0 | $10.0M | $30.9M |
| Gross profit | $2.1M | $2.6M | $0 | $10.0M | $25.6M |
| Operating income | -$61.4M | -$72.9M | -$92.1M | -$115.0M | -$170.1M |
| Net income | -$71.2M | -$73.8M | -$87.4M | -$130.6M | -$209.5M |
| EPS (diluted) | -$4.92 | -$4.57 | -$3.96 | -$3.66 | -$3.02 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $2.1M | $11.2M | $17.5M | $18.7M | $40.1M |
| Net income | -$24.0M | -$64.6M | -$52.1M | -$25.9M | -$98.5M | -$32.9M | -$36.6M | -$34.7M |
| EPS (diluted) | -$0.60 | -$1.70 | -$0.96 | -$0.32 | -$1.35 | -$0.39 | -$0.37 | -$0.35 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$53.5M | -$63.7M | -$86.5M | -$104.8M | -$137.5M |
| Capital expenditure | -$196,000 | $0 | $0 | -$28,000 | $0 |
| Free cash flow | -$53.7M | -$63.7M | -$86.5M | -$104.8M | -$137.5M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $6.7M | $27.4M | $91.4M | $14.2M | $230.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $136.4M
- Total assets
- $206.5M
- Total liabilities
- $156.5M
- Total debt
- $84.3M
- Net debt
- -$52.0M
- Shareholders’ equity
- $50.0M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 18,028,616
- Days to cover
- 6.52
- Change vs previous report
- -1.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 1, 2023
- 1-for-12